Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 7
Submit an article Journal homepage
256
Views
11
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Is complement C1q a potential marker for tumor burden and immunodeficiency in multiple myeloma?

Ronghui YangDepartment of Hematology, Shengjing Hospital of China Medical University, Shenyang, China; ORCID Iconhttp://orcid.org/0000-0002-1825-8275View further author information
ORCID Icon,
Jin HuangDepartment of Radiotherapy, The First Hospital of China Medical University, Shenyang, China; View further author information
,
Huanxin MaDepartment of Hematology, Shengjing Hospital of China Medical University, Shenyang, China; View further author information
,
Shiwen LiDepartment of Hematology, Shengjing Hospital of China Medical University, Shenyang, China; View further author information
,
Xin GaoDepartment of Hematology, Shengjing Hospital of China Medical University, Shenyang, China; View further author information
,
Yingshu LiuDepartment of Laboratory, Shengjing Hospital of China Medical University, Shenyang, ChinaView further author information
,
Jing ShenDepartment of Hematology, Shengjing Hospital of China Medical University, Shenyang, China; View further author information
&
Aijun LiaoDepartment of Hematology, Shengjing Hospital of China Medical University, Shenyang, China; Correspondence[email protected]
View further author information
 show all
Pages 1812-1818 | Received 19 Aug 2018, Accepted 25 Oct 2018, Published online: 10 Jan 2019

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Hanji Huang, Manli Tan, Li Zheng, Guohua Yan, Kanglu Li, Dejie Lu, Xiaofei Cui, Si He, Danqing Lei, Bo Zhu & Jinmin Zhao. (2021) Prognostic Implications of the Complement Protein C1Q and Its Correlation with Immune Infiltrates in Osteosarcoma. OncoTargets and Therapy 14, pages 1737-1751.
Read now

Articles from other publishers (10)

Zhen-ping Hu, Fang Wu, Yuan-hong Du & Mao Ye. (2023) Association between serum complement 1q and the associated factors of acute ischemic stroke in patients with type 2 diabetes. Human & Experimental Toxicology 42.
Crossref
Yan Zhuang, Chenyu Li, Hua Jiang, Lu Li, Yuanteng Zhang, Wei Yu & WeiJun Fu. (2023) Multi-omics investigation of the resistance mechanisms of pomalidomide in multiple myeloma. Frontiers in Oncology 13.
Crossref
Harrison D. Collier-Bain, Frankie F. Brown, Adam J. Causer, Annabelle Emery, Rebecca Oliver, Sally Moore, James Murray, James E. Turner & John P. Campbell. (2023) Harnessing the immunomodulatory effects of exercise to enhance the efficacy of monoclonal antibody therapies against B-cell haematological cancers: a narrative review. Frontiers in Oncology 13.
Crossref
Tharindu Senanayake, Eu Jhin Loh, Rosemary Carroll, Virgil Chan & Stephen R. Smith. (2022) C1q and mobility score in predicting sarcopenia in an Australian cohort of cancer surgery patients. ANZ Journal of Surgery 92:12, pages 3204-3208.
Crossref
Huanglong Yang, Dehui Che, Yuxiang Gu & Dongsheng Cao. (2022) Prognostic and immune-related value of complement C1Q (C1QA, C1QB, and C1QC) in skin cutaneous melanoma. Frontiers in Genetics 13.
Crossref
Lihua Zhang, Xiaosui Ling, Fan Li, Tonghua Yang, Keqian Shi, Shixiang Zhao, Liqun Yu, Zengzheng Li & Haiping He. (2022) Complement 4 Aids in the Prediction of Newly Diagnosed Multiple Myeloma Outcome in Patients. Clinical Medicine Insights: Oncology 16, pages 117955492210791.
Crossref
Huan Li, Juanjuan Chen, Yuanhui Hu, Xin Cai & Pingan Zhang. (2021) Elevated Serum C1q Levels in Children With Sepsis. Frontiers in Pediatrics 9.
Crossref
Shanshan Luo, Moran Wang, Huafang Wang, Desheng Hu, Peter F. Zipfel & Yu Hu. (2020) How Does Complement Affect Hematological Malignancies: From Basic Mechanisms to Clinical Application. Frontiers in Immunology 11.
Crossref
Jiadai Xu, Yifeng Sun, Jifeng Jiang, Zhao Xu, Jing Li, Tianhong Xu & Peng Liu. (2020) Globular C1q Receptor (gC1qR/p32/HABP1) Suppresses the Tumor-Inhibiting Role of C1q and Promotes Tumor Proliferation in 1q21-Amplified Multiple Myeloma. Frontiers in Immunology 11.
Crossref
Shanshan Luo, Desheng Hu, Moran Wang, Peter F. Zipfel & Yu Hu. (2020) Complement in Hemolysis- and Thrombosis- Related Diseases. Frontiers in Immunology 11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.